Cargando…
Divergent functions of NLRP3 inflammasomes in cancer: a review
The cancer is a serious health problem, which is The cancer death rate (cancer mortality) is 158.3 per 100,000 men and women per year (based on 2013–2017 deaths). Both clinical and translational studies have demonstrated that chronic inflammation is associated with Cancer progression. However, the p...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503066/ https://www.ncbi.nlm.nih.gov/pubmed/37715239 http://dx.doi.org/10.1186/s12964-023-01235-9 |
_version_ | 1785106443868831744 |
---|---|
author | Shadab, Alireza Mahjoor, Mohamad Abbasi-Kolli, Mohammad Afkhami, Hamed Moeinian, Parisa Safdarian, Amir-Reza |
author_facet | Shadab, Alireza Mahjoor, Mohamad Abbasi-Kolli, Mohammad Afkhami, Hamed Moeinian, Parisa Safdarian, Amir-Reza |
author_sort | Shadab, Alireza |
collection | PubMed |
description | The cancer is a serious health problem, which is The cancer death rate (cancer mortality) is 158.3 per 100,000 men and women per year (based on 2013–2017 deaths). Both clinical and translational studies have demonstrated that chronic inflammation is associated with Cancer progression. However, the precise mechanisms of inflammasome, and the pathways that mediate this phenomenon are not fully characterized. One of the most recently identified signaling pathways, whose activation seems to affect many metabolic disorders, is the “inflammasome” a multiprotein complex composed of NLRP3 (nucleotide-binding domain and leucine-rich repeat protein 3), ASC (apoptosis associated speck-like protein containing a CARD), and procaspase-1. NLRP3 inflammasome activation leads to the processing and secretion of the proinflammatory cytokines interleukin-1β (IL-1β) and IL-18. The goal of this paper is to review new insights on the effects of the NLRP3 inflammasome activation in the complex mechanisms of crosstalk between different organs, for a better understanding of the role of chronic inflammation in cancer pathogenesis. We will provide here a perspective on the current research on NLRP3 inflammasome, which may represent an innovative therapeutic target to reverse the malignancy condition consequences of the inflammation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12964-023-01235-9. |
format | Online Article Text |
id | pubmed-10503066 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-105030662023-09-16 Divergent functions of NLRP3 inflammasomes in cancer: a review Shadab, Alireza Mahjoor, Mohamad Abbasi-Kolli, Mohammad Afkhami, Hamed Moeinian, Parisa Safdarian, Amir-Reza Cell Commun Signal Review The cancer is a serious health problem, which is The cancer death rate (cancer mortality) is 158.3 per 100,000 men and women per year (based on 2013–2017 deaths). Both clinical and translational studies have demonstrated that chronic inflammation is associated with Cancer progression. However, the precise mechanisms of inflammasome, and the pathways that mediate this phenomenon are not fully characterized. One of the most recently identified signaling pathways, whose activation seems to affect many metabolic disorders, is the “inflammasome” a multiprotein complex composed of NLRP3 (nucleotide-binding domain and leucine-rich repeat protein 3), ASC (apoptosis associated speck-like protein containing a CARD), and procaspase-1. NLRP3 inflammasome activation leads to the processing and secretion of the proinflammatory cytokines interleukin-1β (IL-1β) and IL-18. The goal of this paper is to review new insights on the effects of the NLRP3 inflammasome activation in the complex mechanisms of crosstalk between different organs, for a better understanding of the role of chronic inflammation in cancer pathogenesis. We will provide here a perspective on the current research on NLRP3 inflammasome, which may represent an innovative therapeutic target to reverse the malignancy condition consequences of the inflammation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12964-023-01235-9. BioMed Central 2023-09-15 /pmc/articles/PMC10503066/ /pubmed/37715239 http://dx.doi.org/10.1186/s12964-023-01235-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Shadab, Alireza Mahjoor, Mohamad Abbasi-Kolli, Mohammad Afkhami, Hamed Moeinian, Parisa Safdarian, Amir-Reza Divergent functions of NLRP3 inflammasomes in cancer: a review |
title | Divergent functions of NLRP3 inflammasomes in cancer: a review |
title_full | Divergent functions of NLRP3 inflammasomes in cancer: a review |
title_fullStr | Divergent functions of NLRP3 inflammasomes in cancer: a review |
title_full_unstemmed | Divergent functions of NLRP3 inflammasomes in cancer: a review |
title_short | Divergent functions of NLRP3 inflammasomes in cancer: a review |
title_sort | divergent functions of nlrp3 inflammasomes in cancer: a review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503066/ https://www.ncbi.nlm.nih.gov/pubmed/37715239 http://dx.doi.org/10.1186/s12964-023-01235-9 |
work_keys_str_mv | AT shadabalireza divergentfunctionsofnlrp3inflammasomesincancerareview AT mahjoormohamad divergentfunctionsofnlrp3inflammasomesincancerareview AT abbasikollimohammad divergentfunctionsofnlrp3inflammasomesincancerareview AT afkhamihamed divergentfunctionsofnlrp3inflammasomesincancerareview AT moeinianparisa divergentfunctionsofnlrp3inflammasomesincancerareview AT safdarianamirreza divergentfunctionsofnlrp3inflammasomesincancerareview |